Market Cap | 6.40M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -9.06M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -15.00% |
Sales | 2.41M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -28.00% |
Dividend | N/A | Price/Book | 0.73 | EPS next 5Y | - | 52W High Chg | -81.00% |
Recommedations | - | Quick Ratio | 23.70 | Shares Outstanding | 238.20M | 52W Low Chg | 40.00% |
Insider Own | - | ROA | -6.65% | Shares Float | 430.18M | Beta | 0.15 |
Inst Own | 0.10% | ROE | -12.38% | Shares Shorted/Prior | 39.46K/47.66K | Price | 0.28 |
Gross Margin | 5.06% | Profit Margin | - | Avg. Volume | 33,025 | Target Price | - |
Oper. Margin | -415.73% | Earnings Date | - | Volume | 12,180 | Change | 3.70% |
Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscope. In addition, it is involved in the provision of health treatment services. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.